Balaxi Pharmaceuticals Ltd Share Price

Pharmaceuticals - Indian - Bulk Drugs & Formln M/S

NSE: BALAXI Small Cap ISIN: INE618N01022

As on 03 January 2025 at 14:38 IST

₹74

+ 0.36

(0.49%)

Buy Sell

Over 1 Month

-9.48%

Over 6 Months

-38.30%

Over 1 Year

-14.59%

Over 3 Years

-28.88%

Overview News Financials Corporate Actions

Balaxi Pharmaceuticals Ltd Summary

Close 74

Open 74

High 74

Low 73

Volume 16,151

Net Turnover (in ₹) 60,28,230.74

52 Week High 151.45

52 Week Low 68.91

52Wk High / Low

68.91

151.45

Balaxi Pharmaceuticals Ltd Key Financial Data

Market Cap (in ₹ Cr) 406.55

EPS (TTM) 0.53

Book Value (BV) 23.06

Div. Yield -

P/E (TTM) 138.94

Price/Book Value 3.19

Delivery % 46.39

Face Value 2

Balaxi Pharmaceuticals Ltd Key Ratios

P/E ratio 148.04

P/B ratio 4.59

EV to Sales 38.09

PEG Ratio -1.87

ROA 2.66

ROE 3.42

Debt-Equity 0.13

Net Profit Margin 5.20

Operating Profit Margin 11.04

Balaxi Pharmaceuticals Ltd Peer Comparison

Company	LTP	Market Cap (in ₹ Cr)
Balaxi Pharmaceuticals Ltd	₹73.64	₹406.55
Sun Pharmaceuticals Industries Ltd	₹1,878	₹4,50,595.11
Divis Laboratories Ltd	₹6,143.45	₹1,63,089.29
Cipla Ltd	₹1,537.55	₹1,24,174.70
Mankind Pharma Ltd	₹2,899.55	₹1,19,625.84
Torrent Pharmaceuticals Ltd	₹3,446.25	₹1,16,631.52

Balaxi Pharmaceuticals Ltd News

Balaxi Pharmaceuticals announces board meeting date

On 5 November 2024

30 Oct 2024

Balaxi Pharmaceuticals to conduct AGM

On 23 August 2024

01 Aug 2024

Balaxi Pharmaceuticals to convene board meeting

On 2 August 2024

26 Jul 2024

Balaxi Pharma soars after expanding market presence in Angola & Latin America

Balaxi Pharmaceuticals jumped 5.19% to Rs 126.50 after the company announced strategic hospital partnerships in Angola and securing of tender business in Latin America.

25 Jun 2024

Balaxi Pharmaceuticals to conduct board meeting

On 29 May 2024

24 May 2024

Balaxi Pharmaceuticals Ltd Financials

Standalone

Consolidated

Profit and Loss

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	72.59	114.74	104.04	88.68	46.23
Total Expenses	67.01	92.29	84.34	68.08	37.04
Profit Before Tax	5.58	22.45	19.70	20.60	9.19
Profit After Tax	3.65	16.22	14.67	15.13	6.50
Operating Profit after Depreciation	7.12	22.91	19.76	20.61	9.19

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	7.10	7.89	2.20	0.69	0.19
Total Non Current Assets	31.46	30.70	27.84	20.25	1.21
Total Current Assets	122.90	99.02	54.08	48.67	36.70
TOTAL ASSETS	154.36	129.72	81.92	68.92	37.91
Total Shareholder's Fund	121.55	92.11	57.91	43.25	28.11

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	-1.83	-7.07	8.89	13.46	-14.37
Net Cash used in Investing Activities	0.47	-2.29	-6.87	-20.03	-0.28
Net Cash used in Financing Activities	27.55	26.39	-1.64	3.49	18.10

Profit and Loss

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	241.93	339.07	284.36	233.56	46.23
Total Expenses	201.62	282.15	229.84	189.23	37.43
Profit Before Tax	2.02	56.92	54.52	44.33	8.79
Profit After Tax	-2.39	45.96	47.66	38.14	6.10
Operating Profit after Depreciation	41.99	57.42	54.66	44.34	8.79

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	40.88	41.41	28.76	2.45	0.19
Total Non Current Assets	48.17	46.16	35.47	5.91	1.11
Total Current Assets	210.17	193.51	141	93.77	34.86
TOTAL ASSETS	258.34	239.67	176.47	99.68	35.97
Total Shareholder's Fund	201.36	182.88	113.16	64.98	27.75

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	4.87	6.08	34.14	-	-14.04
Net Cash used in Investing Activities	-1.05	-10.57	-28.45	-5.97	-0.18
Net Cash used in Financing Activities	30.25	25.51	-0.16	3.65	18.10

Balaxi Pharmaceuticals Ltd Corporate Actions

Dividend

Bonus

Splits

Rights

AGM

EGM

No available data

Balaxi Pharmaceuticals Ltd Stock Analysis

Annual revenue for Balaxi Pharmaceuticals Ltd decreased by 36.73% to ₹72.59 crore in FY 2024 from ₹114.74 crore in FY 2023.
Annual Net Profit for Balaxi Pharmaceuticals Ltd decreased by 77.50% to ₹3.65 crore in FY 2024 from ₹16.22 crore in FY 2023.
Promoter Shareholding in Balaxi Pharmaceuticals Ltd remains unchanged by 0.00% in the most recent quarter, from 65.99% in June 2024 to 65.99% in September 2024.
Balaxi Pharmaceuticals Ltd delivered a 1-year return of -14.59% compared to the Nifty 50, which provided a return of 11.64% as of the last trading session.
Balaxi Pharmaceuticals Ltd share price moved up by 0.49% from its previous close of INR ₹73.64. The latest Balaxi Pharmaceuticals Ltd share price is INR ₹74.
Balaxi Pharmaceuticals Ltd share price today has been at a low of 73 and a high of 74. Over the past 52 weeks, the Balaxi Pharmaceuticals Ltd share price has seen a low of 68.91 and a high of 151.45.

FAQ’s

What is the share price of Balaxi Pharmaceuticals Ltd today?

Balaxi Pharmaceuticals Ltd share price as on 3 Jan 2025 is ₹ 74

What is the Market Cap of Balaxi Pharmaceuticals Ltd?

The market cap of Balaxi Pharmaceuticals Ltd stock is ₹406.55 Cr.

What is the PE Ratio of Balaxi Pharmaceuticals Ltd?

The Price to Earnings (P/E) Ratio of Balaxi Pharmaceuticals Ltd is 148.04

What is the PB Ratio of Balaxi Pharmaceuticals Ltd?

The Price to Book (P/B) Ratio of Balaxi Pharmaceuticals Ltd is 4.59

What is the 52 week high of Balaxi Pharmaceuticals Ltd Share Price?

The 52 week high of Balaxi Pharmaceuticals Ltd share price stands at ₹151.45

What is the 52 week low of Balaxi Pharmaceuticals Ltd Share Price?

The 52 week low of Balaxi Pharmaceuticals Ltd share price stands at ₹68.91

Open Free
Demat Account!

Enjoy ₹11 Brokerage on Stocks Delivery

Equity, F&O and
DP Charges